Brendan O'Hara

Brendan O'Hara has extensive work experience in corporate finance and development. Brendan started their career as an Associate at KPMG UK in 2008. Brendan then joined KPMG US in 2004, where they worked as a Senior Manager specializing in the valuation of companies and equity interests, as well as intangible asset valuation services. In 2018, Brendan joined Kaiser Permanente as a Senior Manager until 2021. Currently, they serve as the Associate Director of Corporate Development at Amneal Pharmaceuticals.

Brendan O'Hara holds a Master of Business Administration (MBA) from Columbia Business School. Brendan also obtained a Bachelor's degree in Business Administration with a focus on finance from the University of Richmond. Additionally, Brendan participated in a study abroad program at University College Dublin. Brendan is also a Certified Public Accountant, certified by the Pennsylvania State Board of Accountancy. The month they obtained their certification is not provided.